{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:19:43Z","timestamp":1761128383206},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jbspin.2005.04.008","type":"journal-article","created":{"date-parts":[[2005,10,12]],"date-time":"2005-10-12T11:09:17Z","timestamp":1129115357000},"page":"159-168","source":"Crossref","is-referenced-by-count":10,"title":["Statins in rheumatology"],"prefix":"10.1016","volume":"73","author":[{"given":"Martin","family":"Soubrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2005.04.008_bib1","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2005.04.008_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Sheperd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib3","doi-asserted-by":"crossref","unstructured":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N. Engl. J. Med. 1998;339:1349\u201357.","DOI":"10.1056\/NEJM199811053391902"},{"key":"10.1016\/j.jbspin.2005.04.008_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2005.04.008_bib5","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"issue":"Suppl II","key":"10.1016\/j.jbspin.2005.04.008_bib6","first-page":"42","article-title":"Beyond the laboratory. Clinical implications for statin pleiotropy","volume":"109","author":"Halcox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2005.04.008_bib7","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.283.24.3255","article-title":"Do statins prevent both cardiovascular disease and fracture?","volume":"283","author":"Cummings","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2005.04.008_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2004.022061","article-title":"Do statins offer therapeutic potential in inflammatory arthritis?","volume":"63","author":"McInnes","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.04.008_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2515\/therapie:2003002","article-title":"Mechanisms of actions of statins and fibrate","volume":"58","author":"Duriez","year":"2003","journal-title":"Therapie"},{"key":"10.1016\/j.jbspin.2005.04.008_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and non-lipid effects of statins","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbspin.2005.04.008_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbmr.5650140212","article-title":"The pharmacology of biphosphonates and new insights into their mechanisms of action","volume":"14","author":"Russell","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2005.04.008_bib12","doi-asserted-by":"crossref","first-page":"34967","DOI":"10.1074\/jbc.274.49.34967","article-title":"Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis: a link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase","volume":"274","author":"Reszka","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbspin.2005.04.008_bib13","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2005.04.008_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jcb.20074","article-title":"Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells","volume":"92","author":"Maeda","year":"2004","journal-title":"J. Cell Biochm."},{"key":"10.1016\/j.jbspin.2005.04.008_bib15","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1001\/jama.283.24.3205","article-title":"HMG-CoA reductase inhibitors and the risk of hip fractures","volume":"283","author":"Meier","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2005.04.008_bib16","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0140-6736(00)02400-4","article-title":"Inhibitors of hydroxymethylglutaryl-coenzyme a reductase and risk of fracture among older women","volume":"355","author":"Chan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2005.04.008_bib17","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1001\/jama.283.24.3211","article-title":"HMG-CoA reductase inhibitors and the risk of hip fracture in elderly patients","volume":"283","author":"Wang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2005.04.008_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00198-003-1568-z","article-title":"Hip fracture risk in statin users\u2014a population-based Danish case\u2013control study","volume":"15","author":"Rejnmark","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jbspin.2005.04.008_bib19","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1001\/jama.285.14.1850","article-title":"Use of statins and risk of fractures","volume":"285","author":"Van Staa","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2005.04.008_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(00)04042-3","article-title":"Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomized controlled trial","volume":"357","author":"Reid","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2005.04.008_bib21","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.284.15.1921","article-title":"Statin drugs and the risk of fracture","volume":"284","author":"Pedersen","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2005.04.008_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1006\/bbrc.2000.2697","article-title":"Compactin and simvastatin, but not pravastatin, induce bone morphogenic protein-2 in human sarcoma cells","volume":"271","author":"Sugiyama","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbspin.2005.04.008_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-139-2-200307150-00009","article-title":"Statin use, clinical fracture, and bone density in postmenopausal women: results from the women\u2019s health initiative observational study","volume":"139","author":"LaCroix","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archinte.164.2.146","article-title":"Use of statins and fracture. Results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials","volume":"164","author":"Bauer","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group","volume":"332","author":"Cummings","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib26","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2005.04.008_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2005.04.008_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/oxfordjournals.aje.a009541","article-title":"Risk factors for increased bone loss in an elderly population: the Rotterdam Study","volume":"147","author":"Burger","year":"1998","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib29","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1359\/JBMR.040607","article-title":"HMG-coA reductase inhibitors and the risk of vertebral fracture","volume":"19","author":"Schoofs","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2005.04.008_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S8756-3282(03)00034-6","article-title":"Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study","volume":"32","author":"Montagnani","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2005.04.008_bib31","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0140-6736(00)02408-9","article-title":"Oral statins and increased bone-mineral density in postmenopausal women","volume":"355","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2005.04.008_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/pds.984","article-title":"Statin lipid-lowering drugs and bone mineral density","volume":"14","author":"Solomon","year":"2004","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jbspin.2005.04.008_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archinte.162.5.537","article-title":"Statin use, bone mineral density, and fracture risk","volume":"162","author":"Pasco","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1359\/jbmr.040209","article-title":"Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women","volume":"19","author":"Rejnmark","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2005.04.008_bib35","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs","volume":"292","author":"Graham","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2005.04.008_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1297-319X(02)00389-5","article-title":"Statins and muscles: what price glory?","volume":"69","author":"Hayem","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2005.04.008_bib37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1297-319X(01)00300-1","article-title":"Four cases of tendinopathy in patients on statin therapy","volume":"68","author":"Chazerain","year":"2001","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2005.04.008_bib38","unstructured":"AFSSAPS. Risque musculaire des statines Juin 2002."},{"key":"10.1016\/j.jbspin.2005.04.008_bib39","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib40","first-page":"17","article-title":"Statins in rheumatology","volume":"32","author":"Penney","year":"2005","journal-title":"J. Rheum"},{"key":"10.1016\/j.jbspin.2005.04.008_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJMe048326","article-title":"Statins for atherosclerosis\u2014as good as it gets?","volume":"352","author":"Ehrenstein","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib42","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib43","first-page":"2024","article-title":"Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis","volume":"29","author":"Konda","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1191\/0961203303lu429oa","article-title":"Therapy with statins with refractory rheumatic diseases: a preliminary study","volume":"12","author":"Abud-Mendoza","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2005.04.008_bib45","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of atorvastatin in rheumatoid arthritis (TARA): double blind, randomized placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2005.04.008_bib46","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.4049\/jimmunol.173.12.7641","article-title":"Atorvastatin inhibits autoreactive B cell activation and delays lupus development in new Zealand black\/white F1 mice","volume":"173","author":"Lawman","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000077320","article-title":"Lupus-like syndrome associated with statin therapy","volume":"208","author":"Noel","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.jbspin.2005.04.008_bib48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1191\/0961203303lu313cr","article-title":"Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis","volume":"12","author":"Graziadei","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2005.04.008_bib49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9343(01)00711-2","article-title":"Atorvastatin-induced dermatomyositis","volume":"110","author":"Noel","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"Suppl II","key":"10.1016\/j.jbspin.2005.04.008_bib51","first-page":"II11","article-title":"CRP as a mediator of disease","volume":"109","author":"Yeh","year":"2004","journal-title":"Circulation"},{"issue":"Suppl II","key":"10.1016\/j.jbspin.2005.04.008_bib52","first-page":"II2","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2005.04.008_bib53","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of the first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib54","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib55","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib58","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthrtitis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2005.04.008_bib59","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/1529-0131(200106)44:6<1467::AID-ART243>3.0.CO;2-6","article-title":"Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?","volume":"44","author":"Ward","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib60","first-page":"1072","article-title":"Longterm mortality outcomes in patients with rheumatoid arthritis: early presenters continue to do well","volume":"25","author":"Symmons","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib62","first-page":"1196","article-title":"All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK general practice research database","volume":"30","author":"Watson","year":"2003","journal-title":"J. Rheum"},{"key":"10.1016\/j.jbspin.2005.04.008_bib63","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/art.10419","article-title":"Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients","volume":"46","author":"Goodson","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib64","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib65","first-page":"36","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis","volume":"30","author":"Wolfe","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib66","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"Del Rincon","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib67","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2005.04.008_bib68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.04.008_bib70","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.ATV.0000033516.73864.4E","article-title":"Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis","volume":"22","author":"Bergholm","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib71","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-a treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2005.04.008_bib72","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.STR.26.3.386","article-title":"Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults","volume":"26","author":"Burke","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.jbspin.2005.04.008_bib73","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/art.10269","article-title":"Increased thickness of the arterial intima\u2013media detected by ultrasonography in patients with rheumatoid arthritis","volume":"46","author":"Kumeda","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib74","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.11078","article-title":"Association between atherosclerosis and markers of inflammation in rheumatoid arthritis and healthy subjects","volume":"48","author":"Del Rincon","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib75","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1191\/096120300678828208","article-title":"Epidemiology of cardiovascular disease in systemic lupus erythematosus","volume":"9","author":"Aranow","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2005.04.008_bib76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary disease in patients with systemic lupus erythematosus","volume":"93","author":"Petri","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib77","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib78","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary\u2013artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib79","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib80","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2005.04.008_bib81","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis","volume":"62","author":"Boers","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.04.008_bib82","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis","volume":"26","author":"Park","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib83","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/rheumatology\/keh217","article-title":"Atherosclerosis and lupus","volume":"43","author":"Gorman","year":"2004","journal-title":"Rheumatol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","article-title":"Effect of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study","volume":"113","author":"Park","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib85","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.56.6.374","article-title":"Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis","volume":"56","author":"Munro","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.04.008_bib86","first-page":"1004","article-title":"Intravenous anti-TNF-a antibody therapy leads to elevated triglyceride and reduced LDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis","volume":"114","author":"Gauza","year":"2002","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.jbspin.2005.04.008_bib87","first-page":"252","article-title":"Short term effects of Infliximab on the lipid profile in patients with rheumatoid arthritis","volume":"32","author":"Vis","year":"2005","journal-title":"J. Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.2004.023119","article-title":"Influence of anti-tumor necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis","volume":"64","author":"Popa","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2005.04.008_bib89","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.thromres.2004.06.027","article-title":"Peripheral vascular disease in antiphospholipid syndrome","volume":"114","author":"Vlachoyiannopoulos","year":"2004","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jbspin.2005.04.008_bib90","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case\u2013control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jbspin.2005.04.008_bib91","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jbspin.2005.04.008_bib92","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.20661","article-title":"Effect of glucocorticoids on the arteries in rheumatoid arthritis","volume":"50","author":"Del Rincon","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib93","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1002\/art.11449","article-title":"Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model","volume":"48","author":"Ferrara","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib94","unstructured":"AFSSAPS. Prise en charge th\u00e9rapeutique des patients dyslipid\u00e9miques. Mars 2005."},{"issue":"Suppl","key":"10.1016\/j.jbspin.2005.04.008_bib95","first-page":"S921","article-title":"Traitement hypolip\u00e9miant au cours de la polyarthrite rhumato\u00efde. Une pr\u00e9valence sous-estim\u00e9e","volume":"71","author":"Soubrier","year":"2004","journal-title":"Rev. Rhum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib96","doi-asserted-by":"crossref","unstructured":"Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;16;106:388\u201391.","DOI":"10.1161\/01.CIR.0000020190.45892.75"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2005.04.008_bib97","first-page":"S379","article-title":"Indications for LDL cholesterol lowering interest in rheumatoid arthritis (RA): an underestimated prevalence","volume":"50","author":"Soubrier","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2005.04.008_bib98","first-page":"493","article-title":"Cardiovascular risk factor screening in systemic lupus erythematosus","volume":"30","author":"Al-Herz","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2005.04.008_bib99","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJM200404083501524","article-title":"Central nervous system and limb anomalies in case reports of first-trimester statin exposure","volume":"350","author":"Edison","year":"2004","journal-title":"N. Engl. J. Med."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X05001582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X05001582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T19:49:02Z","timestamp":1553975342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X05001582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1297319X05001582"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2005.04.008","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}